GlassScriptPhysician profile
Luther D Cave
NPI 1831142264
$3,367.75
in general payments reported to CMS, 2019-2025
17 companies · $733 in 2025
The $733 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.16 · 2020: $178 · 2021: $420 · 2022: $763 · 2023: $614 · 2024: $628 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,975.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $467.08 | 2021-2025 | Verquvo, Belsomra |
| Novartis Pharmaceuticals Corporation | $436.79 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $406.79 | 2020-2024 | Xarelto |
| Scpharmaceuticals INC. | $338.34 | 2023-2025 | |
| Pfizer INC. | $332.13 | 2020-2025 | |
| Amgen INC. | $282.58 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $254.59 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $192.35 | 2022-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $140.64 | 2021-2023 | |
| Baxter Healthcare | $95.33 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Abbott Laboratories | $88.22 | 2021 | |
| Atricure, INC. | $85.75 | 2023-2024 | |
| Medtronic Vascular, INC. | $84.34 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.51 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $58.46 | 2024-2025 | Farxiga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $25.57 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $17.28 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luther Cave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.